BIIB
Price:
$200.81
Market Cap:
$29.25B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1991-09-17
Stock Exchange
NASDAQ
Ticker
BIIB
According to Biogen Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 25.29. This represents a change of -256.11% compared to the average of -16.20 of the last 4 quarters.
The mean historical PE Ratio of Biogen Inc. over the last ten years is 19.23. The current 25.29 PE Ratio has changed 13.05% with respect to the historical average. Over the past ten years (40 quarters), BIIB's PE Ratio was at its highest in in the December 2023 quarter at 37.54. The PE Ratio was at its lowest in in the September 2023 quarter at -136.62.
Average
19.23
Median
18.33
Minimum
9.43
Maximum
32.25
Discovering the peaks and valleys of Biogen Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.20%
Maximum Annual PE Ratio = 32.25
Minimum Annual Increase = -47.83%
Minimum Annual PE Ratio = 9.43
Year | PE Ratio | Change |
---|---|---|
2023 | 32.25 | 144.20% |
2022 | 13.21 | -42.55% |
2021 | 22.99 | 133.43% |
2020 | 9.85 | 4.45% |
2019 | 9.43 | -32.25% |
2018 | 13.92 | -47.83% |
2017 | 26.67 | 59.47% |
2016 | 16.73 | -16.06% |
2015 | 19.93 | -27.12% |
2014 | 27.34 | -23.13% |
The current PE Ratio of Biogen Inc. (BIIB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.81
5-year avg
17.54
10-year avg
19.23
Biogen Inc.’s PE Ratio is greater than Bristol-Myers Squibb Company (-15.09), less than AbbVie Inc. (64.08), greater than Merck & Co., Inc. (21.74), less than Gilead Sciences, Inc. (93.22), greater than Johnson & Johnson (10.47), less than Amgen Inc. (55.00), greater than Pfizer Inc. (-62.26), greater than Sanofi (16.51), greater than Novartis AG (14.66), less than GSK plc (33.64),
Company | PE Ratio | Market cap |
---|---|---|
-15.09 | $98.73B | |
64.08 | $341.61B | |
21.74 | $298.70B | |
93.22 | $98.01B | |
10.47 | $395.70B | |
55.00 | $172.25B | |
-62.26 | $161.84B | |
16.51 | $144.70B | |
14.66 | $228.22B | |
33.64 | $89.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biogen Inc.'s PE Ratio?
How is the PE Ratio calculated for Biogen Inc. (BIIB)?
What is the highest PE Ratio for Biogen Inc. (BIIB)?
What is the 3-year average PE Ratio for Biogen Inc. (BIIB)?
What is the 5-year average PE Ratio for Biogen Inc. (BIIB)?
How does the current PE Ratio for Biogen Inc. (BIIB) compare to its historical average?